The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Could a pill offer the brain-boosting benefits of exercise? A recent study in mice, led by scientists at the (USC), suggests ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

The European Medicines Agency said Thursday that its committee evaluating medical products has recommended partial approval ...

A new Alzheimer’s drug has been rejected for widespread use in the NHS in England after the health spending watchdog ruled it “does not currently demonstrate value for the NHS”. The new drug ...

The EU's drugs regulator has recommended approval for Leqembi, a treatment by Eisai and Biogen, for early Alzheimer's disease ...

While growing evidence suggests that there’s a link between blood iron levels and the development of Alzheimer’s disease, new ...

Snyder also noted that “there are barriers and gaps in investment that help move exciting new approaches like this into ...